Cerus Corporation Common Stock (CERS)

About CERS

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Sys…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

261

Website

www.cerus.com/

Fundamentals

1-day range

$2.63$2.73

Market cap

$467.54M

P/E (trailing)

—

P/E (forward)

-530.00

EPS (trailing)

$-0.03

Dividend yield

—

Beta

1.83

Avg. volume

2.67M

Forecasts

3 analyst ratings

Cerus Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• CERS

  Cerus Corporation Common Stock

  $2.65

  ▼ 2.57%
  Market cap $467.54MP/E —
  $1.17$3.47
• NPCE

  Neuropace Inc. Common Stock

  $14.41

  ▲ 1.98%
  Market cap $473.90MP/E —
  $8.76$19.6
• MOBI

  Mobia Medical Inc. Common Stock

  $11.37

  ▲ 7.22%
  Market cap $409.63MP/E —
  $10.19$15.29
• KIDS

  OrthoPediatrics Corp. Common Stock

  $23.67

  ▲ 1.50%
  Market cap $549.03MP/E —
  $14.42$26.74
• SGHT

  Sight Sciences Inc. Common Stock

  $8.54

  ▲ 1.55%
  Market cap $385.77MP/E —
• MDXG

  MiMedx Group Inc Common Stock

  $4.49

  ▼ 0.44%
  Market cap $609.28MP/E 98.12
  $3.03$7.97
• BWAY

  BrainsWay Ltd. American Depositary Shares

  $14.29

  ▼ 0.76%
  Market cap $626.52MP/E 72.19
  $2,391$5,123

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Cerus: This Blood-Safety Underdog Should Be Earning More Respect
  SeekingAlpha · 8/18/2026
• Cerus Corporation 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/8/2026
• Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
  Benzinga · 7/31/2026

• Vivek K. Jayaraman · July 16, 2026 · Sale

  16.7K @ $3.16
• Vivek K. Jayaraman · July 1, 2026 · Grant

  369.7K
• Vivek K. Jayaraman · July 1, 2026 · Grant

  554.5K
• Vivek K. Jayaraman · June 30, 2026 · Sale

  42.4K @ $2.94
• Vivek K. Jayaraman · June 30, 2026 · Grant

  80.0K
• Jensen Chrystal · June 30, 2026 · Sale

  24.3K @ $2.94
• Jensen Chrystal · June 30, 2026 · Grant

  55.0K
• Kevin Dennis Green · June 30, 2026 · Sale

  33.7K @ $2.94
• Kevin Dennis Green · June 30, 2026 · Grant

  63.6K
• William Mariner Greenman · June 30, 2026 · Sale

  101.9K @ $2.94
• William Mariner Greenman · June 30, 2026 · Grant

  192.5K
• Eric Bjerkholt · June 9, 2026 · Sale

  20.5K @ $2.6
• Ann Lucena · June 2, 2026 · Grant

  60.0K
• Eric Bjerkholt · June 2, 2026 · Grant

  60.0K
• Jami K. Nachtsheim · June 2, 2026 · Grant

  60.0K

Institutional Ownership

March 31, 2026

Total shares held

148.38M

Total value held

$262.49M

Institutional holders

164